White label ELPA - ClinicalTrials.eu

Study on Tofacitinib for Patients with Early Active Axial Spondyloarthritis Who Did Not Respond to NSAIDs

Not recruiting

3 1 1 1
Investigated diseases:
- Axial spondyloarthritis
Investigated drugs:
- Naproxen
- Tofacitinib
Study on the Effect of Botulinum Toxin Type A and Sodium Chloride for Patients with Chronic Neuropathic Pain

Not recruiting

3 1 1
Investigated diseases:
- Neuropathy peripheral
Investigated drugs:
- Botulinum Toxin Type A
- Sodium Chloride
Study of Volrustomig for Patients with Advanced Solid Tumors with Mature Tertiary Lymphoid Structures

Not recruiting

2 1 1
Investigated diseases:
- Neoplasm malignant
Investigated drugs:
- Volrustomig
Study Comparing CT-P53 and Ocrelizumab for Patients with Relapsing-Remitting Multiple Sclerosis

Not recruiting

3 1 1 1
Investigated diseases:
- Multiple sclerosis
Investigated drugs:
Study on Long-Term Safety and Efficacy of Deucravacitinib for Patients with Systemic Lupus Erythematosus

Not recruiting

2 1
Investigated drugs:
- Deucravacitinib
Study on the Effectiveness and Safety of RO7434656 for Patients with Primary IgA Nephropathy at High Risk of Progression

Not recruiting

3 1 1
Investigated drugs:
- Isis 696844
+1
Study on the Safety and Effectiveness of R2R01 and Terlipressin for Patients with Hepatorenal Syndrome and Acute Kidney Injury

Not recruiting

2 1 1 1
Investigated diseases:
- Hepatorenal syndrome
- Acute kidney injury
Investigated drugs:
- Terlipressin Acetate
- R2R01
Study on Dapagliflozin for Kidney Protection in Heart Transplant Patients

Not recruiting

3 1 1
Investigated diseases:
- Heart transplant
- Renal failure
Investigated drugs:
- Dapagliflozin
Study on the Safety and Effects of Garadacimab for Preventing Hereditary Angioedema in Children Aged 2 to 11

Not recruiting

3 1 1
Investigated diseases:
- Hereditary angioedema
Investigated drugs:
- Garadacimab
Study Comparing Upadacitinib and Adalimumab for Adults with Moderate to Severe Rheumatoid Arthritis Not Responding to a Single TNF Inhibitor

Not recruiting

3 1 1
Investigated diseases:
- Rheumatoid arthritis
Investigated drugs:
- Adalimumab
- Upadacitinib
+5

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies